Molecules with extended half-lives, compositions and uses thereof

Details for Australian Patent Application No. 2002248184 (hide)

Owner Board of Regents, The University of Texas System Medimmune, Inc.

Inventors Dall'acqua, William; Ward, Elizabeth, Sally; Johnson, Leslie, S.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002248184

PCT Pub. Number WO2002/060919

Priority 60/289,760 09.05.01 US; 60/254,884 12.12.00 US

Filing date 12 December 2001

Wipo publication date 12 August 2002

Acceptance publication date 10 January 2008

International Classifications

G01N 33/534 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with radioactive label

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

A61P 31/16 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/08 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002248184

26 August 2004 Amendment Made

  The nature of the amendment is: Add co-applicant/patentee Board of Regents The University of Texas System

10 January 2008 Application Accepted

  Published as AU-B-2002248184

8 May 2008 Standard Patent Sealed

9 October 2008 Alteration of Name

  The name of the patentee has been altered to Board of Regents, The University of Texas System; MedImmune, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002248185-INHIBITION OF ANGIOGENESIS BY NUCLEIC ACIDS

2002248183-AN EMULSIFIER FOR AN AQUEOUS HYDROCARBON FUEL